IdentifAI-Genetics, part of shizim group, announced that Backed by early-seed funding, they are taking-off after demonstrating there groundbreaking technology on real-life clinical cases.
IdentifAI is revolutionizing the prenatal testing world by offering the first non-invasive fetal genome examination.
By taking a simple blood test from the mother-to-be, we read the embryo's entire DNA, provide an overall analysis and identify severe genetic disorders.
No more risky, complicated, and late-stage invasive tests like Amniocentesis!
